☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
people
Eli Lilly's Verzenio (abemaciclib) Receives the US FDA's Approval for People with HR+ HER2- High Risk Early Breast Cancer
October 13, 2021
Zealand's Zegalogue (dasiglucagon) Receives the US FDA's Approval for the Treatment of Severe Hypoglycemia
March 24, 2021
Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA
March 16, 2021
Celltrion Receives Health Canada's Approval for Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis
February 2, 2021
Roche Reports Long-Term Benefits of Venclexta/Venclyxto Based Combination for R/R Chronic Lymphocytic Leukemia
December 7, 2020
Lilly Signs Agreement with Ypsomed to Advance an Automated Insulin Delivery System for People with Diabetes
November 20, 2020
Load more...
Back to Home